What is the ROE (Return on Equity) of Cochlear this year?
The ROE of Cochlear this year is 0.19 undefined.
Cochlear ROE 2024
Cochlear ROE
0.19
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
In 2024, Cochlear's return on equity (ROE) was 0.19, a 13.04% increase from the 0.17 ROE in the previous year.
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Cochlear's Return on Equity (ROE)
Cochlear's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Cochlear's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Cochlear's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Cochlear’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Cochlear stock
How has the Return on Equity (ROE) of Cochlear developed compared to the previous year?
The ROE of Cochlear has increased by 13.04% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Cochlear?
A high ROE indicates that Cochlear generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Cochlear?
A low ROE can indicate that Cochlear is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Cochlear affect the company?
A change in ROE (Return on Equity) of Cochlear can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Cochlear?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Cochlear?
Some factors that can influence Cochlear's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 5.42 AUD . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Cochlear is expected to pay a dividend of 5.68 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.84 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 26 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 5.68 AUD are expected. This corresponds to a dividend yield of 1.93 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 10/10/2024 amounting to 2.82 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 4.058 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
